Molecular determinants of progression and treatment response in melanoma
Molecular determinants of progression and treatment response in melanoma
批准号:
nhmrc : 1045866
负责人:
Prof Richard Scolyer
金额:
$31.14万
依托单位国家:
澳大利亚
项目类别:
Practitioner Fellowships
财政年份:
2013
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2013-01-01 至 2017-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Melanoma, a skin malignancy of pigment cells, is a major Australian health problem and is the commonest cancer in young adults. This project utilises the resources of the world’s largest melanoma treatment service and aims to develop a scientific basis for 1) improved management of individuals at high risk for melanoma progression, and 2) improved treatment of patients with early and disseminated melanoma, in an era of rapid change in the prospects of successfully treating this dangerous cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improving clinical outcomes of melanoma patients
-
批准号:nhmrc : 1141295
-
项目类别:Practitioner Fellowships
-
资助金额:$39.03万
-
财政年份:2018
-
负责人:Prof Richard Scolyer
-
依托单位:
Improving clinical outcomes of melanoma patients
-
批准号:nhmrc : GNT1141295
-
项目类别:Practitioner Fellowships
-
资助金额:$57.72万
-
财政年份:2018
-
负责人:Prof Richard Scolyer
-
依托单位:
海外基金